6533b86dfe1ef96bd12c9363

RESEARCH PRODUCT

Enzyme replacement therapy in MPS II patients over 20years of age or older at treatment initiation: An international case series from the Hunter Outcome Survey (HOS)

David A.h. WhitemanArvid HeibergChristina Lampe

subject

Series (stratigraphy)medicine.medical_specialtybusiness.industryEndocrinology Diabetes and MetabolismEnzyme replacement therapyBiochemistryOutcome (game theory)SurgeryEndocrinologyInternal medicineGeneticsMedicinebusinessMolecular Biologyhttps://doi.org/10.1016/j.ymgme.2012.11.269